Psychopathological behaviour and cognition in morbid obesity.
CONCLUSION: Psychological, psychoeducational and psychopharmacological treatment can facilitate weight loss in morbid obese subjects with psychopathological comorbidities. A precise definition of the mechanisms affecting appetite, satiety and energy balance is expected to foster the development of new effective antiobesity drugs.
PMID: 28029083 [PubMed - as supplied by publisher]
Source: Recent Patents on Endocrine, Metabolic and Immune Drug Discovery - Category: Endocrinology Tags: Recent Pat Endocr Metab Immune Drug Discov Source Type: research
More News: Bariatric Surgery | Bupropion | Eating Disorders & Weight Management | Endocrinology | Fluoxetine | Neurology | Neurosurgery | Obesity | Prozac | Psychiatry | Psychology | Topamax | Weight Loss | Wellbutrin